1.
Nicole Stadler, Astrid Hasibeder, Pamela Aranda Lopez, Daniel Teschner, Alexander Desuki, Oliver Kriege, Alexander N. R. Weber, Christoph Schulz, Christian Michel, Georg Heβ, Markus P. Radsak. The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation. haematol [Internet]. 2017May1 [cited 2021Dec.7];102(5):e191-e194. Available from: https://haematologica.org/article/view/8084